ArticleScientific reports2026
CNS-active medication use and adverse health outcomes among Thai older adults: a population-based retrospective study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Central nervous system-active (CNS-active) medications should be avoided or used with caution in the older adults because of their associated risks. This study aimed to assess the prevalence of CNS-active medication use among Thai older adults and to evaluate associated health outcomes. We conducted a retrospective study among adults aged 60 years and older in Lampang Province, Thailand. Medical records from January to December 2021 were reviewed to identify prescriptions of CNS-active medication classified as potentially inappropriate medications according to the Beers Criteria. Adverse health outcomes, including falls, hip fractures, hospital admissions, and mortality, were examined. Among 170,709 older adults included in the analysis, 17.30% (n = 29,533) received at least one CNS-active medication. Benzodiazepines were the most commonly prescribed CNS-active medications, with lorazepam being the most frequently used agent. After adjustment for potential confounders, CNS-active medication use was associated with a higher risk of falls (adjusted prevalence ratio [aPR], 1.79; 95% CI, 1.64–1.96; p < 0.001), hospital admission (aPR, 1.82; 95% CI, 1.76–1.83; p < 0.001), and all-cause mortality (aPR, 1.08; 95% CI, 1.00–1.16; p 0.049) compared with non-users. A trend toward an increased risk of hip fracture was also observed (aPR, 1.19; 95% CI, 0.97–1.46; p 0.093). These findings underscore the need for more cautious prescribing practices, enhanced medication review, and targeted interventions to minimize the use of high-risk CNS-active medications in this vulnerable population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.